Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | PRKCA | P17252 | 2/20 | 0.36 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.36 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.36 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | LPAR3 | Q9UBY5 | 5/20 | 0.32 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.32 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6003547 | 0.84 | ADRA2A (0.34) | LMNAALDH1A1MAPT | |
| SCHEMBL98334 | 0.81 | LMNA (0.41) | LMNAALDH1A1MAPTPRKCAPRKCE | |
| SCHEMBL6002424 | 0.81 | ALDH1A1 (0.50) | LMNAALDH1A1PRKCAPRKCEPRKCQ | |
| SCHEMBL2402716 | 0.79 | LMNA (0.50) | LMNAALDH1A1MAPTPRKCAPRKCE | |
| SCHEMBL1171277 | 0.78 | DGKA (0.43) | MAPTTSHRCYP3A4ATMTDP1 | |
| SCHEMBL3086359 | 0.78 | LMNA (0.46) | LMNAALDH1A1MAPTPRKCAPRKCE | |
| SCHEMBL17964469 | 0.77 | ALDH1A1 (0.41) | LMNAALDH1A1MAPTPRKCAPRKCE | |
| SCHEMBL3212549 | 0.77 | TLR2 (0.37) | ALDH1A1TSHRTDP1SMN1; SMN2 | |
| SCHEMBL98666 | 0.77 | PRKCA (0.43) | LMNAALDH1A1MAPTPRKCATSHR | |
| SCHEMBL11679497 | 0.77 | EGLN1 (0.41) | LMNAALDH1A1MAPTPRKCAPRKCE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8283095-B2 | Thiourethane compound and photosensitive resin composition | SHOWA DENKO K.K. (JP) | 2012-10-09 | — | — | US | disclosed |
| US-20100233596-A1 | THIOURETHANE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION | SHOWA DENKO K.K. (JP) | 2010-09-16 | — | — | US | disclosed |
| EP-2055726-A1 | THIOURETHANE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION | Showa Denko K.K. (JP) | 2009-05-06 | — | — | EP | disclosed |
| US-20060036023-A1 | Color filter black matrix resist composition | SHOWA DENKO K.K. (JP) | 2006-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100233596-A1 | THIOURETHANE COMPOUND AND PHOTOSENSITIVE RESIN COMPOSITION | RCOR3, CBR3, TAS2R3 | LMNA 4454/4885ALDH1A1 1341/4885MAPT 712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.